Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Annabis Medical is a Czech-based healthcare company specializing in the research, development, and distribution of medical cannabis and hemp-derived products. As a licensed distributor, the company provides standardized medical cannabis varieties to pharmacies for the treatment of chronic pain, neurological conditions, and oncology-related symptoms. Their product portfolio includes various strains with controlled THC and CBD concentrations, ensuring consistent therapeutic outcomes for patients. In addition to medical cannabis, the company produces a wide range of hemp-based cosmetics and nutritional supplements focused on musculoskeletal and dermatological health. Annabis Medical operates in compliance with European Good Manufacturing Practice (GMP) standards and collaborates with academic institutions to advance cannabinoid research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Annabis Medical.